US Stock MarketDetailed Quotes

ADVM Adverum Biotechnologies

Watchlist
  • 5.3700
  • -0.3500-6.12%
Close Dec 13 16:00 ET
  • 5.3700
  • 0.00000.00%
Post 16:00 ET
111.71MMarket Cap-0.90P/E (TTM)

Adverum Biotechnologies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
1M
0
0
3.6M
0
0
0
3.6M
0
0
Operating revenue
--1M
--0
--0
--3.6M
--0
--0
--0
--3.6M
--0
--0
Cost of revenue
Gross profit
Operating expense
-12.48%30.22M
-36.85%20.88M
-20.69%26.84M
-18.80%127.59M
-22.93%26.16M
-15.86%34.53M
-24.89%33.07M
-11.26%33.84M
2.29%157.14M
-1.39%33.94M
Selling and administrative expenses
-29.06%9.78M
-69.64%3.79M
-10.57%11.43M
-13.73%49.92M
-7.33%10.88M
-19.78%13.79M
-9.40%12.47M
-15.75%12.78M
-10.22%57.86M
-1.29%11.74M
-General and administrative expense
-29.06%9.78M
-69.64%3.79M
-10.57%11.43M
-13.73%49.92M
-7.33%10.88M
-19.78%13.79M
-9.40%12.47M
-15.75%12.78M
-10.22%57.86M
-1.29%11.74M
Research and development costs
-1.45%20.44M
-17.00%17.1M
-26.82%15.41M
-21.76%77.68M
-31.18%15.28M
-13.04%20.74M
-31.94%20.6M
-8.30%21.06M
11.32%99.28M
-1.44%22.2M
Operating profit
15.37%-29.22M
36.85%-20.88M
11.24%-26.84M
21.09%-123.99M
22.93%-26.16M
15.86%-34.53M
24.89%-33.07M
20.70%-30.24M
-7.54%-157.14M
1.39%-33.94M
Net non-operating interest income expense
Other net income (expense)
25.65%2.09M
52.66%2.41M
71.00%2.05M
115.04%5.75M
7.20%1.31M
79.96%1.66M
456.89%1.58M
391.80%1.2M
359.28%2.67M
12,130.00%1.22M
Other non- operating income (expenses)
25.65%2.09M
52.66%2.41M
71.00%2.05M
115.04%5.75M
7.20%1.31M
79.96%1.66M
456.89%1.58M
391.80%1.2M
359.28%2.67M
12,130.00%1.22M
Income before tax
17.45%-27.13M
41.33%-18.48M
14.64%-24.79M
23.45%-118.24M
24.05%-24.85M
18.06%-32.87M
28.01%-31.49M
23.36%-29.04M
-6.13%-154.46M
4.92%-32.72M
Income tax
0
0
0
-1,556.76%-1.08M
-6,063.16%-1.13M
0.00%17K
10.53%21K
-10.53%17K
74K
19K
Net income
17.49%-27.13M
41.36%-18.48M
14.69%-24.79M
24.18%-117.17M
27.56%-23.71M
18.06%-32.89M
28.00%-31.51M
23.35%-29.06M
-6.18%-154.54M
4.86%-32.74M
Net income continuous Operations
17.49%-27.13M
41.36%-18.48M
14.69%-24.79M
24.18%-117.17M
27.56%-23.71M
18.06%-32.89M
28.00%-31.51M
23.35%-29.06M
-6.18%-154.54M
4.86%-32.74M
Minority interest income
Net income attributable to the parent company
17.49%-27.13M
41.36%-18.48M
14.69%-24.79M
24.18%-117.17M
27.56%-23.71M
18.06%-32.89M
28.00%-31.51M
23.35%-29.06M
-6.18%-154.54M
4.86%-32.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
17.49%-27.13M
41.36%-18.48M
14.69%-24.79M
24.18%-117.17M
27.56%-23.71M
18.06%-32.89M
28.00%-31.51M
23.35%-29.06M
-6.18%-154.54M
4.86%-32.74M
Basic earnings per share
60.12%-1.3
71.57%-0.89
48.28%-1.5
25.64%-11.6
29.70%-2.32
18.50%-3.26
28.86%-3.13
23.68%-2.9
-5.41%-15.6
5.71%-3.3
Diluted earnings per share
60.12%-1.3
71.57%-0.89
48.28%-1.5
25.64%-11.6
29.70%-2.32
18.50%-3.26
28.86%-3.13
23.68%-2.9
-5.41%-15.6
5.71%-3.3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 1M003.6M0003.6M00
Operating revenue --1M--0--0--3.6M--0--0--0--3.6M--0--0
Cost of revenue
Gross profit
Operating expense -12.48%30.22M-36.85%20.88M-20.69%26.84M-18.80%127.59M-22.93%26.16M-15.86%34.53M-24.89%33.07M-11.26%33.84M2.29%157.14M-1.39%33.94M
Selling and administrative expenses -29.06%9.78M-69.64%3.79M-10.57%11.43M-13.73%49.92M-7.33%10.88M-19.78%13.79M-9.40%12.47M-15.75%12.78M-10.22%57.86M-1.29%11.74M
-General and administrative expense -29.06%9.78M-69.64%3.79M-10.57%11.43M-13.73%49.92M-7.33%10.88M-19.78%13.79M-9.40%12.47M-15.75%12.78M-10.22%57.86M-1.29%11.74M
Research and development costs -1.45%20.44M-17.00%17.1M-26.82%15.41M-21.76%77.68M-31.18%15.28M-13.04%20.74M-31.94%20.6M-8.30%21.06M11.32%99.28M-1.44%22.2M
Operating profit 15.37%-29.22M36.85%-20.88M11.24%-26.84M21.09%-123.99M22.93%-26.16M15.86%-34.53M24.89%-33.07M20.70%-30.24M-7.54%-157.14M1.39%-33.94M
Net non-operating interest income expense
Other net income (expense) 25.65%2.09M52.66%2.41M71.00%2.05M115.04%5.75M7.20%1.31M79.96%1.66M456.89%1.58M391.80%1.2M359.28%2.67M12,130.00%1.22M
Other non- operating income (expenses) 25.65%2.09M52.66%2.41M71.00%2.05M115.04%5.75M7.20%1.31M79.96%1.66M456.89%1.58M391.80%1.2M359.28%2.67M12,130.00%1.22M
Income before tax 17.45%-27.13M41.33%-18.48M14.64%-24.79M23.45%-118.24M24.05%-24.85M18.06%-32.87M28.01%-31.49M23.36%-29.04M-6.13%-154.46M4.92%-32.72M
Income tax 000-1,556.76%-1.08M-6,063.16%-1.13M0.00%17K10.53%21K-10.53%17K74K19K
Net income 17.49%-27.13M41.36%-18.48M14.69%-24.79M24.18%-117.17M27.56%-23.71M18.06%-32.89M28.00%-31.51M23.35%-29.06M-6.18%-154.54M4.86%-32.74M
Net income continuous Operations 17.49%-27.13M41.36%-18.48M14.69%-24.79M24.18%-117.17M27.56%-23.71M18.06%-32.89M28.00%-31.51M23.35%-29.06M-6.18%-154.54M4.86%-32.74M
Minority interest income
Net income attributable to the parent company 17.49%-27.13M41.36%-18.48M14.69%-24.79M24.18%-117.17M27.56%-23.71M18.06%-32.89M28.00%-31.51M23.35%-29.06M-6.18%-154.54M4.86%-32.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 17.49%-27.13M41.36%-18.48M14.69%-24.79M24.18%-117.17M27.56%-23.71M18.06%-32.89M28.00%-31.51M23.35%-29.06M-6.18%-154.54M4.86%-32.74M
Basic earnings per share 60.12%-1.371.57%-0.8948.28%-1.525.64%-11.629.70%-2.3218.50%-3.2628.86%-3.1323.68%-2.9-5.41%-15.65.71%-3.3
Diluted earnings per share 60.12%-1.371.57%-0.8948.28%-1.525.64%-11.629.70%-2.3218.50%-3.2628.86%-3.1323.68%-2.9-5.41%-15.65.71%-3.3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data